Official AMFI data
Arthkar
LIC

LIC MF Healthcare Fund

Sectoral / ThematicEquity SEBI-regulated

NAV (Direct-Growth)

₹35.7752

As of 3 Jul 2026 · AMFI

AUM

₹88.96 Cr

Expense ratio

0.96%

1Y returns

+11.88%

cat 12.11%

3Y CAGR

+23.09%

cat 22.73%

5Y CAGR

+11.88%

cat 13.72%

Std deviation 3Y

+16.06%

cat 16.29%

In plain English

LIC MF Healthcare Fund is a Sectoral / Thematic scheme from LIC. The portfolio is ~93% in equities with 7% kept in cash and short-term debt. Long-run track record: about 11.9% CAGR over 5 years. Volatility is typical for equity — 20–30 % drawdowns happen during market stress. Worst historical drawdown: -15% in Feb 2025, recovered in 16 months. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

Showing Direct · Growth · INF397L01LK4

NAV (Direct-Growth)

₹35.7752

Last 1Y

+12.92%

Jul 25Min ₹29.62 · Max ₹35.78 · 201 ptsJul 26

Drawdown stories

The crashes you should know about — and how long the fund took to recover.

Feb 2025

-15.1%

Peak ₹33.28 on 5 Dec 2024 → trough ₹28.26 on 28 Feb 2025 (3 months down).

Recovered in 16 months· 1 Jul 2026

Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

4

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

  • Expense ratio

    0.96% — typical for category.

  • AUM size

    ₹89 Cr.

  • Sector concentration

    Top 3 sectors = 96.1% — heavy concentration risk.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

PeriodReturnsCategory avgRank
1W+3.39%+0.29%2/ 18
1M+6.21%+3.93%7/ 18
3M+8.82%+5.61%10/ 18
6M+9.83%+12.10%14/ 18
YTD+10.59%+11.97%14/ 18
1Y+11.88%+12.11%10/ 17
2Y+11.62%+12.10%8/ 14
3Y+23.09%+22.73%7/ 10
5Y+11.88%+13.72%9/ 9
7Y+17.98%+19.14%8/ 8
10Y+13.62%

Portfolio composition

Asset allocation

  • Equity92.92%
  • Cash7.08%

By market cap

  • Large cap33.13%
  • Mid cap29.02%
  • Small cap34.34%
  • Others3.51%

Concentration

Holdings

25

Avg market cap

₹65.9K Cr

Top 10 stocks

55.71%

Top 5 stocks

34.12%

Top 3 sectors

96.12%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight
  • 1

    Sun Pharmaceuticals Industries Ltd

    11.77%
  • 1

    Sun Pharmaceuticals Industries Ltd

    11.22%
  • 2

    Torrent Pharmaceuticals Ltd

    7.08%
  • 3

    Apollo Hospitals Enterprise Ltd

    6.84%
  • 2

    Apollo Hospitals Enterprise Ltd

    6.52%
  • 3

    Torrent Pharmaceuticals Ltd

    6.50%
  • 4

    Aurobindo Pharma Ltd

    5.21%
  • 4

    Aurobindo Pharma Ltd

    5.15%
  • 5

    Divi's Laboratories Ltd

    4.74%
  • 6

    Fortis Healthcare Ltd

    4.70%
  • 5

    Divi's Laboratories Ltd

    4.68%
  • 7

    Neuland Laboratories Ltd

    4.59%
  • 8

    OneSource Specialty Pharma Ltd

    4.56%
  • 6

    Fortis Healthcare Ltd

    4.37%
  • 9

    Piramal Pharma Ltd

    4.33%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff
  • P/E ratio45.9841.09+4.89
  • P/B ratio5.885.83+0.05
  • Price / Sales6.455.71+0.74
  • Price / Cash Flow33.4830.54+2.94
  • Dividend yield0.49%0.63%-0.14
  • Return on equity (ROE)15.36%16.57%-1.21

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y
  • Standard deviation

    Volatility — lower means steadier returns.

    16.2216.0615.2714.9216.2915.44
  • Sharpe ratio

    Risk-adjusted return — higher is better.

    0.410.980.460.480.980.58
  • Sortino ratio

    Like Sharpe but only counts downside volatility.

    0.641.730.720.831.710.94
  • Beta

    1 = moves with the market. <1 = less volatile.

    0.940.940.930.940.950.94

Peers in Sectoral / Thematic

Other schemes in the same SEBI category, ranked by AUM.

Available plans & options

PlanOptionFull nameISIN

Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.